The potential of endothelin antagonism as a therapeutic approach

Author： Benigni Ariela   Perico Norberto   Remuzzi Giuseppe  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.11, 2004-11, pp. : 1419-1435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endotoxin antagonism: conceptual basis and therapeutic potential

By Beutler Bruce  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 2, 2002-04 ,pp. : 147-158

Informa Healthcare

Access to resources Recommend Favorite

Endothelin receptor antagonism: a new approach in the treatment of pulmonary hypertension

By  

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E.   Noll G.   Lüscher T.F.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists in diabetes

By Chakrabarti S.   Cukiernik M.   Mukherjee S.   Chen S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2873-2888

Informa Healthcare

Access to resources Recommend Favorite